PTCB wins contract to certify pharmacy techs in Texas
WASHINGTON The Pharmacy Technician Certification Board has won a contract to provide certification in Texas, the PTCB said Thursday. The organization has certified pharmacy techs in Texas since 1995.
The Texas State Board of Pharmacy selected the PTCB after a bidding and evaluation process that included formal reviews and evaluation.
The TSBP made Texas the first state to require all pharmacy techs to pass the PTCB exam in 1995, and the Texas state legislature made this a law in 2001.
“PTCB believes that patients expect and deserve a high standard of safety when it comes to how their prescription medications are dispensed, and consistent requirements for pharmacy technician certification in every state is an important first step towards meeting those standards,” PTCB executive director and CEO Melissa Murer Corrigan said. “PTCB is excited to continue our work in Texas, and we applaud TSBP’s leadership.”
MinuteClinic opens two Mass. locations
WOONSOCKET, R.I. MinuteClinic, which is owned by CVS Caremark, has expanded its Massachusetts-based clinics to 20 with Wednesday’s opening of two new locations in Hanover and Quincy.
"Since opening our first store-based clinic in Massachusetts in 2008, we have helped to expand access to high-quality, convenient and affordable care to thousands of residents who have visited us at convenient CVS/pharmacy locations near where they live and work," stated Andrew Sussman, president of MinuteClinic and SVP/associate chief medical officer of CVS Caremark. "We are committed to working with the medical community in Massachusetts to build on the state’s precedent-setting efforts to broaden access to quality health services."
According to MinuteClinic, it has had more than 50,000 patient visits in Massachusetts (not including flu shot visits) in less than two years. About 70% of the patients seen at MinuteClinic locations in Massachusetts do not identify a primary care provider. MinuteClinic offers those patients without a primary care provider information on nearby practices accepting new patients.
Hospira extends acquisition offer to Javelin
LAKE FOREST, Ill. Hospira has extended its $145 million offer to buy Javelin Pharmaceuticals, the generic drug maker said Wednesday.
The offer, originally made in April, was set to expire at the end of Tuesday, but will now expire at the end of June 2.
Hospira said Javelin had not satisfied all the conditions for acquisition, which Javelin said was due to a supply-chain problem with the painkiller Dyloject in the United Kingdom, though Javelin expressed disagreement with Hospira’s position.